PARADIGM Survey to Find Out Stakeholders’ Needs and Expectations for Patient Engagement in the Medicines Research and Development Lifecycle
Last days to take part in the PARADIGM survey to improve patient engagement.
PARADIGM is working with all relevant stakeholders to improve the way patients are involved in the medicines lifecycle, particularly in three specific phases: - Research and priority setting - Design of clinical trials - Early dialogue with regulators and HTA bodies
A lifetime of breakthroughs
We were born to end patients’ suffering. To extend life and improve its quality. And right now, after decades of tireless...
Read more
The IMI July newsletter is out, with info on the new Calls for proposals & autumn events...
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.